Clinical Trial Update: GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab [EARLY_Phase 1]

View source ↗

Summary

EARLY Phase 1 clinical trial at Vanderbilt is evaluating the metabolic effects of a GLP-1 receptor agonist in Stage 2 Type 1 Diabetes patients receiving teplizu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist (class) (glucagon-like peptide-1 receptor agonist)
• TZIELD (TEPLIZUMAB-MZWV)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Type 1 Diabetes | EARLY_Phase 1 | Status: RECRUITING